Skip to main content

Jordi Barquinero Mañez

I am an MD, specialized in Internal Medicine, and senior researcher at the Vall d'Hebron Research Institute (VHIR). Doctor from the UAB with Extraordinary Award. I received post-doctoral training at the Fred Hutchinson Cancer Research Center (Seattle). I am currently leading the Gene and Cell Therapy group at the VHIR. My interest has focused on understanding disease mechanisms and finding effective therapies for orphan diseases. In our laboratory we have worked on gene therapy research projects for several rare diseases, mainly of genetic origin.

Institutions of which they are part

Head of group
Gene and Cell Therapy
Vall Hebron Institut de Recerca

Jordi Barquinero Mañez

Institutions of which they are part

Head of group
Gene and Cell Therapy
Vall Hebron Institut de Recerca

I am an MD, specialized in Internal Medicine, and senior researcher at the Vall d'Hebron Research Institute (VHIR). Doctor from the UAB with Extraordinary Award. I received post-doctoral training at the Fred Hutchinson Cancer Research Center (Seattle). I am currently leading the Gene and Cell Therapy group at the VHIR. My interest has focused on understanding disease mechanisms and finding effective therapies for orphan diseases. In our laboratory we have worked on gene therapy research projects for several rare diseases, mainly of genetic origin.

I am an MD specialized in Internal Medicine (Vall d'Hebron University Hospital). I worked at the Intensive Care Unit (HUVH) and the Emergency Department of the Hospital de l'Esperança. I did pre-doctoral studies on autoimmunity at the University of Louisville (Dr. N. Harris) and got my PhD at the Autonomous University of Barcelona with Extraordinary Award, with a work that contributed to the description of a new disease, the primary antiphospholipid syndrome. I was a postdoc at the Fred Hutchinson Cancer Research Center (Dr. R. Storb, Seattle), where I was trained in hematopoietic stem cell gene therapy. I am currently group leader of the gene and cell therapy group (VHIR), where we investigate new therapeutic strategies for rare genetic diseases, mostly in collaboration with other groups on campus and from other national and international institutions. We have participated in research projects using models of multiple sclerosis, hemophilia, MNGIE, in a clinical trial for Fanconi anemia type A (coordinated by Drs. J. Bueren and P. Río, at the CIEMAT (Madrid)), and more recently, in a novel gene therapy approach for muscular dystrophy due to merosin deficiency, in collaboration with the Pediatric Neurology group (Drs. F. Munell and D. Gómez). Our group is part of the national network TERAV (RICORS). I have participated in European projects (INHERINET, CONSERT), including one as coordinator (HEMO-IPS, e-Rare-2), in which we experimentally demonstrated the mutagenic mechanism of the "Royal disease", the form of hemophilia B that affected several European royal families in the 19th and 20th centuries. I participate as a teacher in different master's degrees and I am a member of the American and European Gene and Cell Therapy Societies, and was one of the founding members of the Spanish Society of Gene and Cell Therapy.

Projects

Use of patient-specific induced pluripotent stem cells to improve diagnosis and treatment of hemophilia A (Hemo-Ips)

IP: Jordi Barquinero Mañez
Collaborators: Lluis Martorell Cedres, Sergio López Estévez
Funding agency: Instituto de Salud Carlos III
Funding: 177870
Reference: PI11/03024 (ERANET)
Duration: 01/01/2012 - 30/06/2016

Nuevas estrategias basadas en las células mieloides supresoras expresando autoantígenos para inducir tolerancia. Aplicación en un modelo experimental de esclerosis múltiple

IP: Jordi Barquinero Mañez
Collaborators: Herena Eixarch Ahufinger
Funding agency: Instituto de Salud Carlos III
Funding: 134915
Reference: PI09/00237
Duration: 01/01/2010 - 31/12/2013

Estudi de la implicació de les cèl·lules T reguladores de tipus 1 (Tr1) en la inducció de tolerància antígen específica en el model animal de l'encefalomielitis autoimmune experimental (EAE)

IP: Jordi Barquinero Mañez
Collaborators: -
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 6243
Reference: 2008 BE 1 00114
Duration: 15/09/2008 - 13/05/2009

Unitat de Neuroimmunologia Clínica (UNiC)

IP: Xavier Montalban Gairín
Collaborators: Susana Otero Romero, Carlos Nos Llopis, Sunny Malhotra Sareen, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Silvia Soler García, Carmen Tur Gomez, Jordi Barquinero Mañez, Herena Eixarch Ahufinger, Montserrat Moreno Sánchez, Mar Tintore Subirana, M Jesus Arevalo Navines, Carmen Espejo Ruiz, Angela Vidal Jordana, Joaquin Castillo Justribo, Mireia Castillo Juarez, Nicolás Miguel Fissolo, Georgina Arrambide García
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 43680
Reference: 2009 SGR 793
Duration: 01/01/2010 - 30/04/2014

Related news

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

Related professionals

Montserrat Gomez Perez

Montserrat Gomez Perez

Liver Diseases
Read more
Oleguer Pares Badell

Oleguer Pares Badell

Postdoctoral researcher
Epidemiology and Public Health
Read more
Constanza Olivares Castillo

Constanza Olivares Castillo

Administration and Management
Infectious Diseases
Read more
Marta Garrido Marin

Marta Garrido Marin

Predoctoral researcher
Ophtalmology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.